Avadel climbs as Lundbeck outbids Alkermes in latest bidding war
Avadel Pharmaceuticals (AVDL) announced on Friday that Danish drugmaker Lundbeck (OTCPK:HLBBF) submitted an unsolicited...
Tag: PFE
Metsera shareholders vote to approve $10B sale to Pfizer
Metsera (MTSR) shareholders voted on Thursday to approve the company's $10 billion sale to Pfizer (PFE). The vote came after...
Novo Nordisk gives up battle for Metsera as Pfizer inks $10B deal
Novo Nordisk (NVO) on Saturday said it will no longer increase its buyout offer for Metsera (MTSR) after Pfizer (PFE) won a...
SA Asks: Who’s the next takeover target in the weight-loss drug space?
Weight-loss drugs are back in the news, thanks to the emergence of a bidding war between industry heavyweights Novo Nordisk...
Metsera nears high amid report Novo has raised offer for Metsera
Metsera (MTSR) jumped 13% and was nearing highs of the day after a report that Novo Nordisk (NVO) once again raised its bid...
Viatris raises outlook as emerging markets drive Q3 beat
Viatris (VTRS) shares recorded modest gains in the premarket on Thursday after the Xanax maker exceeded Street forecasts...
Pfizer matches Novo bid for obesity biotech Metsera as takeover battle rages – FT
Pfizer has reportedly matched Novo Nordisk’s (NVO) offer to buy weight-loss drug start-up Metsera (MTSR) for up to $10...
Pfizer loses bid to temporary block Metsera’s Novo Nordisk offer
A judge denied Pfizer's (PFE) request to temporarily block Novo Nordisk's (NVO) $10 billion bid for Metsera. Delaware...
Metsera falls on report FTC has concerns about Novo Nordisk deal
Metsra (MTSR) dropped 4.4% on a report that the Federal Trade Commission may have some concerns about Novo Nordisk's (NVO)...
Pfizer raises full-year 2025 EPS guidance to $3–$3.15 amid Metsera acquisition progress and R&D pipeline expansion
Earnings Call Insights: Pfizer Inc. (PFE) Q3 2025 CEO Albert Bourla highlighted that "the past few months have been pivotal...